Skip directly to searchSkip directly to A to Z listSkip directly to navigationSkip directly to site contentSkip directly to page options

CDC Home

CDC 24/7: Saving Lives. Protecting People. Saving Money Through Prevention.

About CDC.gov

## Tuberculosis (TB)

### Tuberculosis

              - Topics                  - Basic TB Facts                      - Signs & Symptoms
                  - Risk Factors
                  - Exposure to TB
                  - TB Terms 
                - Treatment                      - Latent TB Infection
                  - TB Disease 
                - Testing & Diagnosis
                - TB & HIV Coinfection
                - Infection Control & Prevention
                - Drug-Resistant TB                      - Extensively Drug-Resistant TB    TB in Specific Populations- African-American Community      - Tuberculosis in the African-American Community
  - Stop TB in the African-American Community Summit
  - Background
  - Slideset
  - Slideset Text version
  - Websites 
- Correctional Facility Staff & Inmates        - Table of Contents
  - Introduction
  - Strengthen TB Information Systems and Program Assessment
  - Strengthen TB Environmental Controls and Isolation Practices
  - Provide More Comprehensive and Timely Screening and Diagnostic Evaluations
  - Develop and Strengthen Contact Investigation Protocols
  - Increase HIV Counseling and Testing
  - Increase Staff Training
  - Strengthen Collaboration Between Health Departments and Jails 
- International Travelers
- Pregnancy
- Disaster Responders        - TB Guidance for Disaster Responders
  - TB Guidance for Haiti Earthquake Responders
  - Guidance for Relief Workers and Others Traveling to Haiti 
    Vaccines & Immunizations  Laboratory Information- Drug Susceptibility Testing
- The Uses of Nucleic Acid Amplification Tests for the Diagnosis of TB      - Background
  - General Considerations
  - Research Needs
  - Molecular Drug Susceptibility Tests (DSTs)
  - Communication Plan for New Recommendations
  - General Recommendations of the Expert Panel
  - Recommendations to ACET, CDC, DTBE   
- Rapid Molecular Testing to Detect Drug-Resistant TB in the US      -  Executive Summary
  - Introduction
  -  Background on Tests for Molecular Detection of DR
  -  General Considerations and Principles for a Molecular DR Testing Service �
  -  Possible Scenarios and Scope of Testing for a Molecular DR Testing Service
  -  Research Needs
  -  General Recommendations of the Expert Panel
  -  Communication Plan for the Report
  -  Recommendations
  -  References
  -  Panel Members and CDC Participants
  - Appendix 1
  - Appendix 2
  - Appendix 3   
- Interim Laboratory Biosafety Guidance for XDR *Mycobacterium* tuberculosis strains
- Molecular Detection of Drug Resistance (MDDR)
- Laboratory User Guide: MDDR in *Mycobacterium tuberculosis*      - Introduction
  - Molecular Detection of Drug Resistance  (MDDR) service
  - Use of the MDDR service by submitters
  - References 
    Research- TB Epidemiologic Studies Consortium      - Background
  - Infrastructure
  - Research Projects
  - Publications
  - Meetings
  - Directory
  - TBESC Committee Members
  - Translating Research into Practice (TRIP)
  - Contact TBESC
  - Prospective Evaluation of Immunogenetic and Immunologic Markers for Susceptibility to Tuberculosis Infection and Progression from M. Tuberculosisinfection to active TB
  - Zero Tolerance for Pediatric TB
  - Models for Incorporating HIV Counseling, Testing, and Referral into Tuberculosis Contact Investigations
  - Prevalence of Latent TB Infection Among High Risk Populations in the United States
  - Regional Capacity-Building in Low-Incidence Areas
  - Use of Network Analysis Methods to Characterize M. tuberculosis Transmission Patterns Among Women and Other High-Risk Populations
  - An Analysis of Molecular Epidemiology of Multi-Drug Resistant M. tuberculosisin the United States
  - Missed Opportunities for TB Prevention in Foreign-Born Population in the United States and Canada
  - New Model for Assessing TB Surveillance and Action Performance and Cost
  - Addressing TB Among African Americans in the Southeast: Identifying and Overcoming Barriers to Treatment Adherence for Latent TB Infection and TB Disease
  - Assessing the TB Knowledge, Attitudes, Beliefs, and Practices Among Private Providers Serving Foreign-born Populations at Risk for TB
  - Factors Associated with Acceptance of, Adherence to and Toxicity From Treatment for Latent TB Infection and Pilot Study of Treatment for Latent TB Infection Effectiveness
  - Culturally Appropriate TB Educational Materials for Leaders and Staff of Hispanic Service Organizations
  - Enhancing TB Programs� Capacity for Self-Evaluation: Testing New Tools and Developing an Evaluation Toolkit
  - African Refugee Women�s Health Improvement Project
  - Evaluation of the TK Medium: A New Rapid Solid Culture System for Tuberculosis
  - Evaluation of New Interferon-y Release Assays in the Diagnosis of Latent TB Infection in Health Care Workers
  - Request for Proposal 
- TB Trials Consortium      - Background and Infrastructure
  - Study Sites
  - Projects
  - Contact TBTC 
- Behavioral & Social Science Research
    
                - Data & Statistics                      - Reported TB in the US, Surveillance Report                        - Archived Surveillance Reports and Slide Sets 
                  - TB in the United States, Slide Set 
                - Education & Training                      - Health Care Provider & TB Program Materials  Patient & General Public Materials  Continuing Education  Regional Training & Medical Consultation Centers- Curry International Tuberculosis Center
- Heartland National Tuberculosis Center
- Southeastern National Tuberculosis Center
- New Jersey Medical School Global Tuberculosis Institute
    TB Education & Training Network- Annual Conference      - Agenda
  - Past Conferences 
- Join TB ETN
- Members Only Section 
- Steering Committee & Workgroups
- Project Excellence and TB Educator of the Year Awards      - Eligibility Criteria and Nomination Requirements
  - Submitting Nominations   
- Contact TB ETN
- Horizon Health Education Program Award
    Find TB Resources.org  Electronic Mailing Lists  
                  - Resources for TB Programs                        - Program Evaluation
                    - Genotyping                          - TB GIMS                            - User Roles and Access Levels
                        - Instructions for Accessing TB GIMS
                        - Implementation Schedule
                        - State TB Lab Implementation Schedule 
                      - Guide to the Application of Genotyping to Tuberculosis Prevention and Control 
                    - TB Information Management                          - Tuberculosis Information Management System (TIMS) Replacements                            - TB Patient Management Project
                        - TB Patient Management Project
                        - Technical Specifications for TB Surveillance Systems 
                    - International Notification of TB Cases                          - International TB Notification Form  Programmatic Support- Site Visits
- Program Consultant
Laws and Policies
Menu of Suggested Provisions For State Tuberculosis Prevention and Control Laws
Fact sheet - Menu of Suggested Provisions For State Tuberculosis Prevention and Control Laws

          Publications & Products- Fact Sheets      - General        - Fact sheets - Spanish
    - TB - General Information
    - The Difference Between Latent TB Infection and Active TB Disease
    -  Diferencia entre la infección de tuberculosis latente y enfermedad   de tuberculosis activa 
    - A Global Perspective on TB
    - Tuberculosis Information for Employers in Non-Healthcare Settings
    - Bovine Tuberculosis in Humans
    - Tuberculosis Information for International Travelers
    - TB Can Be Treated
    - Exposure to TB
    - TB and HIV/AIDS
    - You Can Prevent TB
    - Testing for TB
    - Tuberculosis: informaci�n general 
    - Diferencia entre la infecci�n de tuberculosis latente y enfermedad de tuberculosis activa
    - Informaci�n sobre la tuberculosis para los viajeros internacionales
    - Exposición a la tuberculosis
    - Usted puede prevenir la tuberculosis
    - La tuberculosis puede ser tratada
    - Tuberculosis y VIH/SIDA
    - Usted puede prevenir la tuberculosis
    - Pruebas para detectar la tuberculosis 
  - Data & Statistics        - A Global Perspective on TB
    - Trends in Tuberculosis – United States
    - The Revised Report of Verified Case of Tuberculosis
    - The National Tuberculosis Indicators Project (NTIP)
    - National Tuberculosis Indicators Project (NTIP): Frequently Asked Questions 
    - TB Genotyping
    - TB Genotyping Information Management System (TB GIMS) 
  - Drug-Resistant TB        - Multidrug-Resistant Tuberculosis (MDR TB)
    - Extensively Drug-Resistant Tuberculosis (XDR TB)
    - CDC’s Role in Preventing Extensively Drug-Resistant Tuberculosis (XDR TB)
    - Tuberculosis multirresistente (MDR)
    - Tuberculosis extremadamente resistente (XDR)
    - El papel de los CDC en la prevenci�n de la tuberculosis extremadamente resistente (XDR) 
  - Infection Control & Prevention        - You Can Prevent TB
    - Respiratory Protection in Health-Care Settings
    - Infection Control in Health-Care Settings
    - Tuberculosis Information for International Travelers 
  - TB in Specific Populations        - Tuberculosis Information for Employers in Non-Healthcare Settings
    - Tuberculosis in Minorities
    - Tuberculosis Information for International Travelers
    - TB and HIV/AIDS
    - Recommendations for Human Immunodeficiency Virus (HIV) Screening in Tuberculosis (TB) Clinics
    - Treatment of Drug-Susceptible Tuberculosis Disease in HIV-Infected Persons
    - Tuberculosis in Blacks
    - Tuberculosis and Pregnancy
    - Tuberculosis y embarazo 
  - Treatment        - TB Can Be Treated
    - Treatment of Latent TB Infection
    - Treatment of Latent Tuberculosis Infection: Maximizing Adherence
    - Treatment Options for Latent Tuberculosis Infection
    - Treatment of Drug-Resistant Tuberculosis
    - Treatment of Drug-Susceptible Tuberculosis Disease in Persons Not Infected with HIV
    - Treatment of Drug-Susceptible Tuberculosis Disease in HIV-Infected Persons
    - Tratamiento de la infecci�n de tuberculosis latente 
  - Testing & Diagnosis        - TB Can Be Treated
    - Testing for TB
    - Recommendations for Human Immunodeficiency Virus (HIV) Screening in Tuberculosis (TB) Clinics
    - Interferon-Gamma Release Assays (IGRAs)
    - Tuberculin Skin Testing
    - Diagnosis of Tuberculosis Disease
    - Targeted Tuberculin Testing and Interpreting Tuberculin Skin Test Results
    - Prueba cutánea de la tuberculina
    - Diagnóstico de la tuberculosis activa 
  - Vaccines & Immunizations        - BCG Vaccine
    -  Vacuna BCG 
- Guidelines      - Contact Investigations
  - Control & Elimination
  - Drug-Resistant TB
  - Genotyping
  - Infection Control & Prevention
  - Laboratory
  - TB & HIV
  - TB in Specific Populations        - Correctional Facilities
    - Elderly Persons
    - Foreign-born
    - Homeless
    - Migrant Farm Workers
    - Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis 
  - Testing & Diagnosis
  - Treatment
  - Vaccines & Immunizations
  - Guidelines by Date 
- Guides & Toolkits      - Core Curriculum        - Core Curriculum on TB
    - Core Curriculum CE 
  - Self-Study Modules        - Continuing Education Activities
    - Slide Set Facilitator Guide 
  - Report of Verified Case of Tuberculosis (RVCT)
  - Forging Partnerships to Eliminate TB        - Toolkit 
  - Understanding the TB Cohort Review Process
  - Latent Tuberculosis Infection: A Guide for Primary Health Care Providers
  - Effective TB Interviewing for Contact Investigation
  - Mantoux Tuberculin Skin Testing Products
  - Ethnographic Guides 
- Newsletters      - TB Notes
  - TB Challenge 
- Pamphlets, Brochures, Booklets      - Questions and Answers       - Introduction
    - Latent TB Infection
    - Active TB Disease
    - Glossary of Terms
    - Índice
    - Introducción
    - Infección de tuberculosis latente
    - Tuberculosis activa
    - Glosario 
  - TB Elimination: Now is the Time!        - Graph 1
    - Graph 2
    - Graph 3 
  - TB and HIV Coinfection
  - Patient Education Series        - English Only
    - English/Spanish
    - English/Tagalog 
  - Tuberculosis - Get the Facts        - Tuberculosis - La tuberculosis: lo que debe saber 
  - Tuberculosis - The Connection between TB and HIV        - Tuberculosis - La  tuberculosis: Conexi�n entre la TB y el VIH 
- Posters      - Mantoux Tuberculin Skin Test Wall Chart
  - World TB Day        -                                                  Afiches 
    - 2011 Poster (English)
    - 2011 Poster (Spanish)
    - 2010 Poster (English)
    - 2010 Poster (Spanish)
    - 2008 Poster (English)
    - 2008 Poster (Spanish)
    - 2006 Poster (English)
    - 2004 Poster (English)
    - 2004 Poster (Spanish)
    - 2003 Poster (English)
    - 2003 Poster (Spanish)
    - 2003 Now is the Time Poster (English)
    - 2003 Now is the Time Poster (Spanish) 
  - Think TB      - Think TB (En Espanol) 
  - Stop TB 
- Reports & Articles        - *Morbidity and Mortality Weekly Reports (MMWRs)*        - Contact Investigations
    - Control and Elimination
    - Data & Statistics
    - Drug-Resistant Tuberculosis
    - Infection Control & Prevention
    - Laboratory
    - TB in Specific Populations
    - Foreign-Born
    - High-Risk Settings
    - Homeless
    - International
    - Occupational Groups
    - Travel
    - TB & HIV
    - Testing & Diagnosis
    - Treatment
    - LTBI Updates
    - Vaccines & Immunizations
    - World TB Day 
  - DTBE Authored Journal Articles        - 2011
    - 2010
    - 2009
    - 2008
    - 2007
    - 2006 
  - Tuberculosis Laboratory Aggregate Reports
- Slide Sets      - Core Curriculum        - Text- only version 
  - Self-Study Modules        - Module 1 (text only)
    - Module 2 (text only)
    - Module 3 (text only)
    - Module 4 (text only)
    - Module 5 (text only) 
  - Prevention and Control of Tuberculosis in Correctional and Detention Facilities
  - Guidelines for Preventing the Transmission of M. TB in Health care Settings
  - Investigation of Contacts of Persons with Infectious TB        - Text-Only version
    - Introduction
    - Decisions to Initiate a Contact Investigation
    - Investigating the Index Patient and Sites of Transmission
    - Assigning Priorities to Contacts
    - Diagnostic and Public Health Evaluation of Contacts
    - Medical Treatment for Contacts with LTBI
    - When to Expand a Contact Investigation
    - Communicating Through the News Media
    - Data Management and Evaluation of Contact Investigations
    - Confidentiality and Consent in Contact Investigations
    - Staff Training for Contact Investigations
    - Contact Investigations in Special Circumstances
    - Source-Case Investigations
    - Cultural Competency and Social Network Analysis
    - Resources 
  - Epidemiology of Pediatric Tuberculosis in the United States        - Text-Only version
    - Introduction
    - Pediatric TB Cases by Age and Race
    - Pediatric TB Cases by Origin of Birth
    - Pediatric Cases, Percentages and Rates by States
    - Pediatric TB Cases by Case Verification Criterion and Site of Disease
    - Pediatric TB Cases in Specific Groups 
    - Pediatric TB Cases Case Completion
    - Slide 1
    - Slide 2
    - Slide 3
    - Slide 4
    - Slide 5
    - Slide 6
    - Slide 7
    - Slide 8
    - Slide 9
    - Slide 10
    - Slide 11
    - Slide 12
    - Slide 13
    - Slide 14
    - Slide 15
    - Slide 16
    - Slide 17
    - Slide 18
    - Slide 19
    - Slide 20
    - Slide 21
    - Slide 22
    - Slide 23
    - Slide 24
    - Slide 25
    - Slide 26
    - Slide 27
    - Slide 28
    - Slide 29
    - Slide 30
    - Slide 31 
  - Treatment of TB
  - Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis Infection
  Introduction 
- Videos, DVDs, CD Roms
- Electronic Tools & Resources
- Web-Based Courses & Webinars      - Multidrug-Resistant Tuberculosis (MDR TB) and Extensively-Drug Resistant (XDR) TB        - MDR TB Webinar Agenda
    - MDR TB Webinar Slideset
    - MDR TB Webinar Slideset (text only)
    - MDR TB Webinar Transcript
    - Continuing Education Credits   
  - TB 101 for Health Care Workers        - TB 101 CE Credits   
  - Program Evaluation 
          Events- World TB Day      - Activities        - 2012 State activities
    - 2011 activities
    - 2011 State activities
    - 2010 activities
    - 2010 State activities
    - 2009 activities
    - 2008 activities
    - 2007 activities
    - 2006 activities 
  - Resources        - Web Tools
    - 2011 Web Tools
    - 2010 Web Tools
    - 2009 Web Tools 
  - History 
          Links- State TB Control Offices
- TB Control Programs
About Us
Mission Statement and  Activities
DTBE Strategic Planning

Organization Chart
Advisory Groups
Federal TB Task Force
Table of Contents
Executive Summary
Introduction
Chronology in the Development of This Report
Strategies for Maintaining Control of TB
Strategies for Accelerating the Decline of TB
Activities for Developing New Tools
Global U.S. Actions
Assessing the Impact of Actions Taken
Federal TB Task Force Members and Others Involved in the Development of This Report
Glossary
References
Federal TB Task Force Roster

Table of Contents
Executive Summary
Introduction
How to Eliminate TB? – The IOM Report
Why Eliminate TB? – Rationale for Elimination
Who Will Lead? – CDC's Response
Goal I: Maintain control of TB
Goal II: Accelerate the decline
Goal III: Create new tools
Goal IV: Reduce the global burden of TB
Goal V: Summon and sustain support
Goal VI: Track progress
References

Table of Contents
DTBE Fact Sheet Menu
DTBE Fact Sheet
IOM PowerPoint file

Funding

                       TB Challenge: Partnering to Eliminate TB			in African Americans
TB Challenge: Partnering to Eliminate TB in African Americans is               a quarterly newsletter disseminated from CDC to it's traditional               and non-traditional partners, which include, academicians, health               care providers, public health leaders, policy, and decision-makers,               religious and community leaders, state and local health department               representatives, and others who service African Americans and their               communities.
- Summer 2009  (  PDF  - 277K)
              Archived TB Challenge
The documents listed below are historical, archived information.   The information contained in these documents, while accurate at the time of   release, may not be the most current available.
- Spring 2008  (  PDF  - 375K)

 
       - Text size:
- s
- m
- l
- xl
- Email page
- Print page
- Bookmark and share    - Add this to...
  - Favorites
  - Delicious
  - Digg
  - Facebook
  - Google Bookmarks
  - Twitter 
						﻿			
- Listen to audio/Podcast
Contact Us:- Centers for Disease Control and Prevention  		Division of Tuberculosis Elimination (DTBE)          1600 Clifton Rd., NE          MS E10  		Atlanta, GA 30333
- 800-CDC-INFO  		(800-232-4636)  		TTY: (888) 232-6348
- New Hours of Operation  		8am-8pm ET/Monday-Friday  		Closed Holidays
- [email protected]
    File Formats Help:- 
- 
- 
- 
- 
- 
- 
- 

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site? 
- Email
- Print
- Share    - Add this to...
  - Favorites
  - Delicious
  - Digg
  - Facebook
  - Google Bookmarks
  - Twitter 
- Updates
- Listen
- Page last reviewed: July 1, 2010
- Page last reviewed: July 1, 2010
- Content source:  Division of Tuberculosis Elimination
  - Home
- A-Z Index
- Site Map
- Policies
- About CDC.gov
- Link to Us
- All Languages
- CDC Mobile
- Contact CDC
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348, New Hours of Operation 8am-8pm ET/Monday-Friday		Closed Holidays - [email protected]  A-Z Index- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
- #